|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Notice to Readers: Blast Lung Injury: What Clinicians Need to KnowWorldwide terrorist activity increases the risk for injuries related to explosions; however, few health-care providers in the United States have experience treating these injuries. To address this concern, CDC has added the fact sheet, "Blast Lung Injury: What Clinicians Need to Know" to the Mass Trauma Preparedness and Response page on the CDC website (http://www.bt.cdc.gov/masstrauma/index.asp). Basic clinical information regarding the presentation, evaluation, management, and outcomes of blast lung injury (BLI) is provided; a chest radiograph of BLI also is included. BLI is a direct consequence of a blast wave from a high-explosive detonation striking the body and is a major cause of morbidity and mortality both at the scene and among initial survivors. The impact on lungs results in tearing, hemorrhage, contusion, and edema. BLI is a clinical diagnosis characterized by respiratory difficulty and hypoxia, which can occur without obvious external injury to the chest. BLI presents unique triage, diagnostic, and management challenges. A list of references and readings on BLI is provided with the fact sheet. Information regarding other injuries resulting from explosions is provided on the Mass Trauma Preparedness and Response page.
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Date last reviewed: 7/27/2005 |
|||||||||
|